AstraZeneca's $39 billion takeover of U.S.-based Alexion Pharmaceuticals examined by U.K. regulator
#astrazeneca
#alexionpharmaceuticals
3 years ago By Lawce — The deal has already been approved by the U.S. and Canadian authorities.